Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Avivagen, Inc. (OTC: CHEXF).

Full DD Report for CHEXF

You must become a subscriber to view this report.


Recent News from (OTC: CHEXF)

Avivagen Announces the Issuance of Shares
OTTAWA, May 02, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by sa...
Source: GlobeNewswire
Date: May, 02 2018 16:30
Avivagen Announces its Attendance at the Bloom Burton & Co. Healthcare Investor Conference
OTTAWA, May 01, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by sa...
Source: GlobeNewswire
Date: May, 01 2018 16:30
Avivagen Announces OxC-beta(TM) Purchase Order with New Customer
OTTAWA, April 25, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”) is a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, b...
Source: GlobeNewswire
Date: April, 25 2018 06:30
Avivagen Announces the Issuance of Stock Options
OTTAWA, April 13, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by ...
Source: GlobeNewswire
Date: April, 13 2018 16:15
Avivagen Announces Results from Its Annual General Meeting
OTTAWA, April 10, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by ...
Source: GlobeNewswire
Date: April, 10 2018 16:30
Avivagen Announces an Amendment to its Stock Option Plan
OTTAWA, April 05, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by ...
Source: GlobeNewswire
Date: April, 05 2018 06:30
Avivagen Announces Continued Growth and Adoption in the Commercial Use of OxC-beta(TM) Livestock in the Philippines
OTTAWA, March 26, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by ...
Source: GlobeNewswire
Date: March, 26 2018 06:30
Cesar Millan's Highly Recommended Vivamune(TM) Scheduled for Global Pet Expo Debut
OTTAWA, March 19, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“ Avivagen ” or the “ Company ”), a life sciences innovation company with a series of patent protected products that support and optimize human and animal health, is pleased to ...
Source: GlobeNewswire
Date: March, 19 2018 06:30
Avivagen Announces Approval from TSX Venture Exchange for Extension of Warrants
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. OTTAWA, March 12, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“ Avivagen ” or...
Source: GlobeNewswire
Date: March, 12 2018 06:30
Avivagen Announces CEO Update and January 31, 2018 Financial First Quarter Results
OTTAWA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“ Avivagen ” or the “ Company ”), a life sciences innovation company with a series of patent protected products that support and optimize human and animal health, announces an up...
Source: GlobeNewswire
Date: February, 27 2018 06:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-21N/A0.41N/AN/A0
2018-08-20N/A0.41N/AN/A0
2018-08-17N/A0.41N/AN/A0
2018-08-16N/A0.41N/AN/A0
2018-08-150.410.410.410.412,000

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-02-26200200100.0000Short
2018-01-24200200100.0000Short
2017-10-241,2001,200100.0000Short
2017-10-1330,00030,50098.3607Short
2017-09-297,7008,70088.5057Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CHEXF.


About Avivagen, Inc. (OTC: CHEXF)

Logo for Avivagen, Inc. (OTC: CHEXF)

Not available

 

Contact Information

 

 

Current Management

  • Cameron Groome / CEO

Current Share Structure

     



    Daily Technical Chart for (OTC: CHEXF)

    Daily Technical Chart for (OTC: CHEXF)


    Stay tuned for daily updates and more on (OTC: CHEXF)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (OTC: CHEXF)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CHEXF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of CHEXF and does not buy, sell, or trade any shares of CHEXF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/